一、部分代表作（*共同）

1.Ge, Y., Wu, X., Zhang, W.  Wang X*,et al. Effects of public-health measures for zeroing out different SARS-CoV-2 variants. Nat Commun 14, 5270 (2023).

2.Wang XL, Guo XH, Xin QQ,et al. Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients. Clin Infect Dis. 2020;71(10):2688-2694. 

3.Wang XL, Lin X, Yang P, et al. Coronavirus disease 2019 outbreak in Beijing's Xinfadi Market, China: a modeling study to inform future resurgence response. Infect Dis Poverty. 2021 May 7;10(1):62. 

4.Wang XL, Xu WG, Hu YS, et al. Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction. Hum Vaccin Immunother. 2023 Aug 1;19(2):2227549.

5.Shen Y, Liu YH, Jiao XK, Cai YX, Xu X, Yao H, Wang XL（通讯）. Knowledge Graph: Applications in Tracing the Source of Large-Scale Outbreak - Beijing Municipality, China, 2020-2021. China CDC Wkly. 2023 Jan 27;5(4):90-95.

6.Wang XL, Zhang PF, Li J, et al. Enterovirus D68 in a 6-year-old acute flaccid myelitis case in China, 2018: a case report. BMC Infect Dis. 2020 Feb 11;20(1):125.

7.Wang XL, An ZJ, Huo D, et al. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China. Hum Vaccin Immunother. 2019;15(5):1183-1190. 

8.Li SQ*, Wang XL*, Li L, et al. Factors Associated with SARS-CoV-2 Repeat Positivity - Beijing, China, June-September 2020. China CDC Wkly. 2022 Feb 4;4(5):88-95.

9.Cao Y*, Wang XL*, Li SQ, et al.  A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial. Sci China Life Sci. 2022;65(8):1677-1679.

10.Wang X, Zeng D, Seale H, et al.Comparing early outbreak detection algorithms based on their optimized parameter values. J Biomed Inform. 2010 43(1):97-103. 

11.Wang X , Yang P , Seale H ,et al.Estimates of the True Number of Cases of Pandemic (H1N1) 2009, Beijing, China.Emerging Infectious Diseases, 2010, 16(11):1786-1788.

12.Wang X,WuS,Macintyre,C.R.,et al.Using an Adjusted Serfling Regression Model to Improve the Early Warning at the Arrival of Peak Timing of Influenza in Beijing. Plos One, 2015, 10(3):e0119923.

二、科技成果奖

1.2011年获中华预防医学会科学技术奖三等奖——北京市传染病预警技术的研究及应用（第8名）

2.2022年获北京预防医学会科学技术奖二等奖——北京市手足口病流行规律、疾病负担及EV71疫苗保护效果评价研究（第1名）